drugset / Trial / NCT03880734

This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance Were Assessed at Baseline and at 26th Weeks.

NCT03880734

RandomizedParallel-groupOpen-labelSupportive care

Summary

Vitamin D3 supplementation doen not change lung functions and exercise tolerance in vitamin D3 deficient ACO patient was the null hypothesis of the research.

Timeline

Start
2018-03-01
Primary completion
2018-11-01
Completion
2019-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 80000 iu Oral

Indications